CU Cancer Center
LightNews LightNews
banner
cucancercenter.bsky.social
CU Cancer Center
@cucancercenter.bsky.social
220 followers 76 following 300 posts
Official Bluesky page of the University of Colorado Cancer Center at CU Anschutz- Colorado's only NCI-designated comprehensive cancer center.
Posts Replies Media Videos
cucancercenter.bsky.social
Is your New Year's resolution to quit tobacco products? With the 2Morrow Health app, Colorado residents over the age of 13 get 12 months of free acceptance and commitment therapy. Learn more about the program and sign up here: https://bit.ly/40CQ3ws
January 6, 2026 at 5:56 PM
cucancercenter.bsky.social
Four in 10 cancer cases are preventable! Make cancer prevention a goal for the new year. Here are 10 ways you can prevent cancer in 2026 ⬇️
https://news.cuanschutz.edu/cancer-center/schulick-fischer-studts-top-10-prevention
A collage of activities that prevent or contribute to cancer. There is a photo of a glass of alcohol being poured. Someone smoking a cigarette. A women running. A women putting on sunscreen. A closeup photo of a fruit salad. And someone stepping on a scale.
January 5, 2026 at 11:48 PM
cucancercenter.bsky.social
With funding from a NIH grant, CU Cancer Center's Dan Regan, DVM, and Breelyn Wilky, MD, are studying a fibroblast-targeting drug, in conjunction with standard-of-care chemotherapy, in dogs with naturally occurring osteosarcoma ⬇️
https://bit.ly/48RmRrf
A New Method for Stopping Osteosarcoma from Spreading to the Lungs
Dan Regan, DVM, and Breelyn Wilky, MD, are teaming to study a new drug combination in dogs and humans to stop osteosarcoma from spreading to the lungs.
news.cuanschutz.edu
January 2, 2026 at 11:03 PM
cucancercenter.bsky.social
@oncodaily.bsky.social has named Enrique Soto Pérez de Celis, MD, PhD, CU Cancer Center's associate director for global oncology, as one of the 100 Most Influential People in Oncology in 2025! 👏 ⬇️
https://oncodaily.com/community/enrique-soto-427482
Enrique Soto Recognized among The 100 Most Influential People in Oncology in 2025 - OncoDaily
Enrique Soto Recognized among The 100 Most Influential People in Oncology in 2025 / cancer, Enrique Soto, OncoDaily, Oncology, The 100 Most Influential People
oncodaily.com
January 2, 2026 at 6:52 PM
cucancercenter.bsky.social
✨ Best of the CU Cancer Center newsroom in 2025 ✨

@drcamidge.bsky.social has spent his career fighting lung cancer. In 2022, that fight turned personal when he received a diagnosis of his own.

Read this story: https://bit.ly/3MMXsGI
See the other top stories: bit.ly/4j3ONLW
Graphic that is promoting Top Stories of 2025. The title text reads "‘World Lung Cancer Expert Diagnosed with Advanced Lung Cancer" in CU gold. There is a big #1 in white. There is a smaller text line in white "In this candid reflection, Camidge shares insights on empathy, shifting research priorities, and strategies to help patients."
January 1, 2026 at 1:30 AM
cucancercenter.bsky.social
✨ Best of the CU Cancer Center newsroom in 2025 ✨

Virginia Borges, MD, director of the Young Women’s Breast Cancer Translational Program at the CU Cancer Center, explores contributing factors.

Read this story: https://bit.ly/3MMXsGI
See the other top stories: bit.ly/4j3ONLW
Graphic that is promoting Top Stories of 2025. The title text reads "‘What’s Driving the Growing Number of Breast Cancer Cases in Young Women?" in CU gold. There is a big #2 in white. There is a smaller text line in white "American Cancer Society report shows a troubling increase in breast cancer among women under 50."
December 30, 2025 at 6:05 PM
cucancercenter.bsky.social
✨ Best of the CU Cancer Center newsroom in 2025 ✨

New research from @jdegregori.bsky.social, PhD, suggests that COVID-19 may awaken dormant cancer cells, potentially increasing recurrence risk in certain patients.

Read this story: https://bit.ly/48CQlI3
See the other top stories: bit.ly/4j3ONLW
Graphic that is promoting Top Stories of 2025. The title text reads "‘CU Cancer Center Research Shows COVID-19 Can Awaken Dormant Cancer Cells" in CU gold. There is a big #3 in white. There is a smaller text line in white "The study showed that respiratory viral infections can promote metastatic progression in cancer survivors."
December 29, 2025 at 11:31 PM
cucancercenter.bsky.social
✨ Best of the CU Cancer Center newsroom in 2025 ✨

The FDA advises those with a family history of medullary thyroid cancer to avoid GLP-1 drugs. Bryan Haugen, MD, breaks down the science.

Read this story: https://bit.ly/44ECOyx
See the other top stories: https://bit.ly/4j3ONLW
Graphic that is promoting Top Stories of 2025. The title text reads "‘Does Using GLP-1 Drugs, Like Zepbound, Increase Your Risk of Thyroid Cancer?" in CU gold. There is a big #4 in white. There is a smaller text line in white "As GLP-1 receptor agonists gain popularity, questions about their link to thyroid cancer persist."
December 29, 2025 at 3:55 AM
cucancercenter.bsky.social
✨ Best of the CU Cancer Center newsroom in 2025 ✨

Learn what younger women need to know about fertility and pregnancy when they are diagnosed with breast cancer.

Read this story: https://bit.ly/4jehaar
See the other top stories: https://bit.ly/4j3ONLW
Graphic that is promoting Top Stories of 2025. The title text reads "‘Bachelorette’ Star’s Breast Cancer Diagnosis Raises Questions About Pregnancy" in CU gold. There is a big #5 in white. There is a smaller text line in white "Katie Thurston met with fertility specialists and read about women who gave birth during and after treatment."
December 28, 2025 at 3:01 AM
cucancercenter.bsky.social
✨ Best of the CU Cancer Center newsroom in 2025 ✨

Richard Wood, MD, Rachel Kruse, MD, and Eden Bernstein, MD, share strategies for counseling patients on reducing alcohol-related cancer risk.

Read this story: https://bit.ly/3WzJwSv
See the other top stories: https://bit.ly/4j3ONLW
Graphic that is promoting Top Stories of 2025. The title text reads "Alcohol is a Leading Cause of Cancer, But Will the Public Heed a New Warning?" in CU gold. There is a big #6 in white. There is a smaller text line in white "Despite clear evidence linking alcohol consumption to several cancers, patient awareness remains low."
December 26, 2025 at 5:55 PM
cucancercenter.bsky.social
✨ Best of the CU Cancer Center newsroom in 2025 ✨

Catherine Danis, PhD, and M. Eric Kohler, MD, PhD, developed ALA-CART, aimed to improve outcomes for lymphocytic cancer patients.

Read this story: https://bit.ly/4qn9zc3
See the other top stories: https://bit.ly/4j3ONLW
Graphic that is promoting Top Stories of 2025. The title text reads "New CAR-T Cell Therapy Shows Promise for Hard-to-Treat Cancers" in CU gold. There is a big #7 in white. There is a smaller text line in white "Catherine Danis, PhD, and M. Eric Kohler, MD, PhD, developed a supercharged iteration of CAR-T cell therapy."
December 25, 2025 at 7:13 PM
cucancercenter.bsky.social
✨ Best of the CU Cancer Center newsroom in 2025 ✨

Matthew Sikora, PhD, explains why lobular breast cancer can be harder to diagnose and how new research is paving the way for better treatments.

Read this story: https://bit.ly/47B9b2S
See the other top stories: https://bit.ly/4j3ONLW
Graphic that is promoting Top Stories of 2025. The title text reads "An Understudied Type of Breast Cancer Poses a Lurking Threat" in CU gold. There is a big #8 in white. There is a smaller text line in white "Lobular breast cancer is the second most common type of breast cancer, yet it often goes undetected."
December 24, 2025 at 6:27 PM
cucancercenter.bsky.social
During the holidays, it can be difficult to talk about cancer with a loved one who was newly diagnosed. CU Cancer Center's Kyle Concannon, MD, offers advice: https://bit.ly/3XPpALp
In big bold white text "TALKING TO SOMEONE WITH CANCER DURING THE HOLIDAYS". In bold black text "WITH KYLE CONCANNON, MD". In regular black text, a list "Keep it simple. Don't focus on how things should go. Be there for them, however they might need it.". There is a circle framed photo of a family having holiday dinner. The background is a blurred photo of a christmas tree.
December 24, 2025 at 4:16 PM
cucancercenter.bsky.social
✨ Best of the CU Cancer Center newsroom in 2025 ✨

When Denver Broncos' Alex Singleton faced a testicular cancer diagnosis, his journey underscored the importance of early detection and patient-centered care.

Read this story: https://bit.ly/3MBsHV6
See the other top stories: https://bit.ly/4j3ONLW
Graphic that is promoting Top Stories of 2025. The title text reads "What Men Can Learn From Alex Singleton’s Testicular Cancer Diagnosis" in CU gold. There is a big #9 in white. There is a smaller text line in white "Nicholas Cost, MD, shares key takeaways on recognizing symptoms and what to expect for treatment and recovery."
December 23, 2025 at 6:08 PM
cucancercenter.bsky.social
✨ Best of the CU Cancer Center newsroom in 2025 ✨

Swati Patel, MD, breaks down why prep matters, so you can take this important step in preventing colorectal cancer with confidence.

Read this story: https://bit.ly/3R3oR5V
See the other top stories: https://bit.ly/4j3ONLW
Graphic that is promoting Top Stories of 2025. The title text reads "Everything You Wanted to Know About Colonoscopy Prep (But Were Afraid to Ask)" in CU gold. There is a big #10 in white. There is a smaller text line in white "Getting ready for a colonoscopy can feel intimidating—but it doesn’t have to be."
December 22, 2025 at 4:39 PM
cucancercenter.bsky.social
CU Cancer Center researcher Zachary Clayton, PhD, is investigating whether high-intensity interval training prior to chemotherapy can prevent premature vascular aging for breast cancer patients ⬇️
https://bit.ly/4rXrjw2
How Exercise May Prevent Cardiovascular Disease in Breast Cancer Survivors
Researcher Zachary Clayton is investigating whether high-intensity interval training prior to chemotherapy can prevent premature vascular aging.
news.cuanschutz.edu
December 22, 2025 at 3:58 AM
cucancercenter.bsky.social
Congrats to CU Cancer Center members @drcamidge.bsky.social, MD, PhD, Russell Glasgow (@russgl.bsky.social), PhD, and Angelo D’Alessandro (@dalessandrolab.bsky.social), PhD, for being named on the Clarivate Highly Cited Researchers 2025 list! 👏
A graphic with a blurred background that is a photo of the CU Anschutz campus after snowfall. There is three photos with names under each one, it reads " D. Ross Camidge, MD, PhD, Russell Glasgow, PhD, Angelo D' Allessandro, PhD". There is a headline that reads "Highly Cited Researchers 2025"
December 21, 2025 at 3:31 AM
cucancercenter.bsky.social
CU Cancer Center member Jonathan Samet, MD, MS, shares his reflection on the 80th anniversary of the atomic bombings of Hiroshima and Nagasaki, Japan, and the research the Radiation Effects Research Foundation has been doing with survivors ⬇️
https://bit.ly/4rVKnuC
Radiation Researcher Reflects on 80th Anniversary of Atomic Bombings of Hiroshima and Nagasaki
Jonathan Samet is a councilor with the Radiation Effects Research Foundation, studying the long-term effects of radiation on survivors of the bombings.
news.cuanschutz.edu
December 20, 2025 at 1:00 AM
cucancercenter.bsky.social
Happy Holidays! For four decades, we’ve worked toward one goal, prevent and conquer cancer. In 2026, we keep moving forward—together.
December 19, 2025 at 6:11 PM
cucancercenter.bsky.social
Molishree Joshi, PhD, and Kimberly Jordan, PhD, leaders of two CU Cancer Center shared resources, have received the first-ever National Cancer Institute R50s for core-based scientists at CU Anschutz (@cuanschutz.bsky.social)! 👏

Learn more: https://bit.ly/4s2TXMd
Photos of Molishree Joshi and Kimberly Jordan in two bubbles surrounded by CU branded circles.
December 19, 2025 at 2:28 AM
cucancercenter.bsky.social
Congrats to Tim Milosich and Kelly McIlvride, MAcc, CMA, on their new roles! Milosich has been promoted to clinical trials finance program director, and McIlvride has been promoted to Cancer Center finance program director. 👏
The background is a blurred photo of campus during a snowy day. There is a photo of Tim Milosich and Kelly McIlvride, bordered in black boxes. In black text on CU gold rounded rectangles it reads "Tim Milosich. clinical trials finance program director." and "Kelly McIlvride, MAcc, CMA. Cancer Center finance program director".
December 18, 2025 at 6:53 PM
cucancercenter.bsky.social
Yesterday afternoon, CU Cancer Center staff gathered to celebrate the accomplishments made in 2025 while enjoying cookies, showing off of holiday sweaters, and of course, good company! 🎉 ❄️
Two attendees at the party sharing their cookies. Group photo of CU Cancer Center staff at this year's winter celebration get together. They're all smiling for the camera and standing over a table with cookies on it. Group photo of CU Cancer Center staff at this year's winter celebration get together. At one of the tables at the party, one staff member is holding up their phone with a prompt that they're trying to guess as part of a game. Everyone else at the table is trying to help them guess the prompt.
December 18, 2025 at 4:17 PM
cucancercenter.bsky.social
With a Tumor Host Interactions Program grant along with the mentorship of two CU Cancer Center investigators, Migachelle Romano is researching how obesity-driven inflammation is promoting pancreatic cancer progression ⬇️
https://bit.ly/4j1ITuW
Post-Baccalaureate Researcher Receives Grant for Investigation of Obesity in Pancreatic Cancer
CU Cancer Center members Carlo Marchetti, PhD, and Curtis Henry, PhD, are mentoring Migachelle Romano in her research on obesity and pancreatic cancer.
news.cuanschutz.edu
December 18, 2025 at 1:06 AM
cucancercenter.bsky.social
#ASH25: Did you know that clonal hematopoiesis affects at least 20% of adults over 60? Cancer Center's @ericpietras.bsky.social, PhD, shares his insights on the role of this condition in cancer and aging at the 2025 American Society of Hematology Presidential Symposium ⬇️
https://bit.ly/3KOKdoi
Rewriting the Rulebook of Blood
At ASH 2025, Eric Pietras, PhD, highlights how aging, inflammation, and metabolism drive clonal hematopoiesis—and shape cancer and cardiovascular risk.
bit.ly
December 17, 2025 at 1:06 AM
cucancercenter.bsky.social
Congratulations to Matt Lee! Lee stepped into his new position as program director of clinical research operations at the Cancer Clinical Trials Office after multiple roles since 2014.
A graphic celebrating Matt Lee being the new Cancer Clinical Trials Office (CCTO) program director of clinical research operations. The background is a blurred photo of campus during a snowy day. There is a photo of Matt bordered in a black box. In black text on a CU gold rounded rectangle it reads "Matt Lee. Program Director of Clinical Research Operations".
December 16, 2025 at 6:12 PM